{
    "850f305d-14db-4c75-b547-79470a557ea3-1078310": {
        "articles": {
            "resultCount": 6,
            "results": [
                {
                    "body": "Rome, November 27 - Italian authorities on Thursday suspended use of two batches of the FLUAD flu vaccine amid suspicions it may have caused three deaths. They also called on anyone who might have unused doses of FLUAD from lots numbered 142701 and 143301 to contact their doctor. \"Three fatalities took place within 48 hours of the administration of doses from two batches (of FLUAD),\" the Italian Pharmaceutical Agency (AIFA) said. Two of the suspicious deaths linked to the vaccine occurred in Sicily, while the other was in the southern Molise region, ANSA sources said. The two batches were produced at a Novartis plant in the Tuscan city of Siena for use by local public health clinics. AIFA stressed that the move suspending use of the vaccine is a precaution pending tests of samples from the batches. Health authorities in the northwestern Liguria region have suspended flu vaccinations while clinics and pharmacies check their stocks to make sure they don't have any from the suspicious batches.",
                    "date": "2014-11-27",
                    "eventUri": "1895631",
                    "id": "26443150",
                    "isDuplicate": false,
                    "lang": "eng",
                    "sim": 0.885,
                    "source": {
                        "title": "www.gazzettadelsud.it",
                        "uri": "www.gazzettadelsud.it"
                    },
                    "time": "22:04:00",
                    "title": "Use of flu vaccine halted following three deaths - update",
                    "uri": "229658053",
                    "url": "http://www.gazzettadelsud.it/news/118347/Use-of-flu-vaccine-halted-following-three-deaths---update.html",
                    "wgt": 1
                },
                {
                    "body": "Rome, November 28 - The death of a fourth person may be linked to the Fluad flu vaccine, Florence's La Nazione daily reported Friday. On Thursday the Italian authorities suspended use of two batches of the Novartis-produced vaccine as a precautionary measure amid suspicions it may have been linked to three deaths. The fourth suspicious death regards an 80-year-old man who died in the Tuscan city of Prato on Thursday, after taking the vaccine on Wednesday, La Nazione reported. The man reportedly was administered a dose of the vaccine from one of the two suspended batches. The Italian Pharmaceutical Agency (AIFA) has called on anyone who might have unused doses of Fluad from lots numbered 142701 and 143301 to contact their doctor. Two of the previous suspicious deaths linked to the vaccine occurred in Sicily, while the other was in the southern Molise region, ANSA sources said. The two batches were produced at a Novartis plant in the Tuscan city of Siena for use by local public health clinics. AIFA stressed that the move suspending use of the vaccine is a precaution pending tests of samples from the batches. Health authorities in the northwestern Liguria region have suspended flu vaccinations while clinics and pharmacies check their stocks to make sure they don't have any from the suspicious batches.",
                    "date": "2014-11-28",
                    "eventUri": "1895631",
                    "id": "26466556",
                    "isDuplicate": false,
                    "lang": "eng",
                    "sim": 0.8621,
                    "source": {
                        "title": "www.gazzettadelsud.it",
                        "uri": "www.gazzettadelsud.it"
                    },
                    "time": "10:37:00",
                    "title": "Fourth death linked to halted flu vaccine - report - update2",
                    "uri": "229754834",
                    "url": "http://www.gazzettadelsud.it/news/118392/Fourth-death-linked-to-halted-flu-vaccine---report---update2.html",
                    "wgt": 1
                },
                {
                    "body": "ROME: Italy suspended the use of a flu vaccine made by Swiss pharmaceuticals giant Novartis on Thursday (Nov 27) amid fears it may have caused three deaths.\n\nThe Italian Pharmaceutical Agency (AIFA) banned the use of two batches of the Fluad vaccine after three people who had received it died and a fourth was taken seriously ill.\n\nThe victims were two women aged 87 and 79 and a 68-year old man, all of whom died between Nov 12 and 19 in southern Italy, according to Italian media reports. The fourth person, a 92-year old man, is in hospital in a serious condition.\n\n\"Novartis has been notified by AIFA of the precautionary suspension of two lots of Fluad in Italy following reports of the serious adverse effects events after vaccination. No causal relationship to the vaccine has been established,\" the Swiss company said. A review of the two batches \"have confirmed that they are in conformity with all production and quality standards,\" it said.\n\nHealth officials called for calm as news of the ban spread. Italian consumer association Codacons called on the health minister to suspend pro-vaccination campaigns, but AIFA insisted vaccines were \"a precious resource and irreplaceable for the prevention of seasonal flu.\"\n\n\"We need to make sure that the number of people who get vaccinated does not drop. We have to have faith in vaccines,\" said AIFA head Sergio Pecorelli, who added that \"8,000 people die of seasonal flu\" each year. The suspected batches were produced at a Novartis plant in the Tuscan city of Siena.\n\nThe Swiss company said Fluad had been used since 1997, during which time over 65 million doses have been successfully administered throughout the world, \"which confirms the data gathered during clinical studies which involved over 70,000 patients.\"",
                    "date": "2014-11-27",
                    "eventUri": "1895631",
                    "id": "26445945",
                    "isDuplicate": false,
                    "lang": "eng",
                    "sim": 0.7974,
                    "source": {
                        "title": "Channel NewsAsia",
                        "uri": "www.channelnewsasia.com"
                    },
                    "time": "23:10:00",
                    "title": "Italy bans Novartis flu vaccine after suspicious deaths",
                    "uri": "229668736",
                    "url": "http://www.channelnewsasia.com/news/business/international/italy-bans-novartis-flu/1498126.html",
                    "wgt": 1
                },
                {
                    "body": "AIFA said it had not yet established whether there was a direct link between the drug and the fatalities and had imposed the ban only as a precaution. Novartis said in a statement that no causal relationship had been established.\n\n\"The three events that ended in fatalities began within 48 hours after doses from the two batches of vaccine were administered,\" AIFA said on its website.\n\nThe watchdog said samples of the drug had been taken for tests and it was waiting for the results in order to assess a possible causal link between the vaccine and the deaths.\n\nHowever, Novartis said that a review of the two batches had confirmed that they are \"in conformity with all production and quality standards\". It said it was working with AIFA to assess the matter further.\n\nAIFA advised people who might have packets of batches 142701 and 143301 of the FLUAD vaccine to stop using it and contact their doctor.",
                    "date": "2014-11-27",
                    "eventUri": "1895631",
                    "id": "26444665",
                    "isDuplicate": false,
                    "lang": "eng",
                    "sim": 0.795,
                    "source": {
                        "title": "Reuters",
                        "uri": "www.reuters.com"
                    },
                    "time": "22:29:00",
                    "title": "Italy's pharmaceutical watchdog raises alarm on batches of flu drug",
                    "uri": "229662554",
                    "url": "http://www.reuters.com/article/2014/11/27/us-italy-vaccine-idUSKCN0JB2CX20141127?feedType=RSS&feedName=healthNews",
                    "wgt": 1
                },
                {
                    "body": "Fatalities came within 48 hours of FLUAD administration\n\n(ANSA) - Rome, November 27 - The Italian authorities on Thursday halted the use of two batches of the FLUAD flu vaccine amid suspicions that three deaths may have been linked to doses of it.\n\n\"Three fatalities took place within 48 hours of the administration of doses from two batches (of FLUAD),\" the Italian Pharmaceutical Agency (AIFA) said explaining its decision to halt the use of the batches of the drug.\n\nAIFA stressed that the move was precautionary.\n\nTwo of the suspect deaths linked to the drug occurred in Sicily, while the other was in the southern Molise region, ANSA sources said.",
                    "date": "2014-11-27",
                    "eventUri": "1895631",
                    "id": "26436389",
                    "isDuplicate": false,
                    "lang": "eng",
                    "sim": 0.7926,
                    "source": {
                        "title": "La Gazzetta del Mezzogiorno",
                        "uri": "www.lagazzettadelmezzogiorno.it"
                    },
                    "time": "19:22:00",
                    "title": "Use of flu drug batches halted following three deaths",
                    "uri": "229633722",
                    "url": "http://www.lagazzettadelmezzogiorno.it/english/use-of-flu-drug-batches-halted-following-three-deaths-no772380/",
                    "wgt": 1
                },
                {
                    "body": "Italy has suspended the use of two batches of an anti-flu vaccine made by Swiss firm Novartis amid reports that three deaths may have been linked to the drug.\n\nItaly's pharmaceutical watchdog AIFA said the suspension of Fluad was a precautionary measure.\n\nThe victims were two elderly women and an elderly man, according to Italian media reports.\n\nNovartis said \"no casual relationship to the vaccine has been established\".\n\nA review of the two batches \"have confirmed that they are in conformity with all production and quality standards,\" the company said.\n\nIt added that Fluad had been used since 1997, during which time more than 65 million doses have been successfully administered around the world.",
                    "date": "2014-11-27",
                    "eventUri": "1895631",
                    "id": "26444882",
                    "isDuplicate": false,
                    "lang": "eng",
                    "sim": 0.7858,
                    "source": {
                        "title": "BBC",
                        "uri": "www.bbc.co.uk"
                    },
                    "time": "22:33:00",
                    "title": "Italy suspends flu drug over deaths",
                    "uri": "229663362",
                    "url": "http://www.bbc.co.uk/news/world-europe-30240620#sa-ns_mchannel%3Drss%26ns_source%3DPublicRSS20-sa",
                    "wgt": 1
                }
            ]
        },
        "info": {
            "articleCount": 6,
            "averageDate": "2014-11-28",
            "avgCos": 0.5796,
            "categories": [
                {
                    "label": "Health/Child_Health/Immunizations",
                    "uri": "http://www.dmoz.org/Health/Child_Health/Immunizations",
                    "wgt": 31
                }
            ],
            "customDate": false,
            "customLocation": false,
            "eventUri": "1895631",
            "extractedDate": "",
            "extractedDateEnd": "",
            "id": "1863659",
            "lang": "eng",
            "location": {
                "country": {
                    "labelEng": "Italy",
                    "lat": 42.83333,
                    "long": 12.83333,
                    "wikiUri": "http://en.wikipedia.org/wiki/Italy"
                },
                "labelEng": "Rome",
                "lat": 41.89474,
                "long": 12.4839,
                "wikiUri": "http://en.wikipedia.org/wiki/Rome"
            },
            "storyDate": "2014-11-28",
            "storyDateEnd": "",
            "uri": "850f305d-14db-4c75-b547-79470a557ea3-1078310",
            "variance": 0.1641
        }
    },
    "e7e700df-6a06-44ea-a4f3-f736278fc36b-357640": {
        "articles": {
            "resultCount": 5,
            "results": [
                {
                    "body": "Roma, 28 nov (EFE).- La Agencia italiana del F\u00e1rmaco (AIFA) anunci\u00f3 hoy estar investigando el fallecimiento de once personas a quienes en los \u00faltimos d\u00edas se les hab\u00eda suministrado una dosis de la vacuna Fluad, de la compa\u00f1\u00eda Novartis Vaccines and Diagnostics.\n\n\"La Aifa est\u00e1 recopilando todos los elementos necesarios para verificar caso por caso los avisos recibidos\", explic\u00f3 la agencia en un comunicado.\n\nEn la nota la AIFA a\u00f1ade que \"por el momento no es posible afirmar que haya una relaci\u00f3n directa entre el suministro de la vacuna y las muertes se\u00f1aladas, dado que esto requiere informaciones m\u00e1s completas que deben ser fruto de cuidados an\u00e1lisis\".\n\nAyer este mismo organismo prohibi\u00f3 como \"medida de precauci\u00f3n\" la venta de dos lotes de esta vacuna tras la muerte de dos personas en Sicilia (sur de Italia) que hab\u00edan sido vacunadas 48 horas antes, una medida que ha suscitado la pol\u00e9mica en el pa\u00eds.\n\nPor esta raz\u00f3n, la AIFA considera \"posible\" que el \"repentino aumento de las notificaciones\" pueda ser fruto del \"impacto medi\u00e1tico sobre la poblaci\u00f3n\".\n\nPor el momento, las fiscal\u00edas de las ciudades donde se han producido estas muertes -como las toscanas Prato y Siena (centro)- han abierto una investigaci\u00f3n, seg\u00fan recogen los medios.\n\nEn la nota, la AIFA recuerda \"la importancia de la vacuna contra la gripe\", una enfermedad \"infecciosa seria\" que puede derivar en \"complicaciones graves\".\n\nSeg\u00fan informaron los medios, esta vacuna no ha sido distribuida en el extranjero, sino \u00fanicamente en Italia.",
                    "date": "2014-11-28",
                    "eventUri": "1895631",
                    "id": "26498092",
                    "isDuplicate": false,
                    "lang": "spa",
                    "sim": 0.7881,
                    "source": {
                        "title": "LaVanguardia",
                        "uri": "www.lavanguardia.com"
                    },
                    "time": "21:21:00",
                    "title": "Italia investiga 11 muertes que podr\u00edan deberse a una vacuna ... - La Vanguardia",
                    "uri": "229860865",
                    "url": "http://www.lavanguardia.com/vida/20141128/54420864799/italia-investiga-11-muertes-que-podrian-deberse-a-una-vacuna-contra-la-gripe.html",
                    "wgt": 1
                },
                {
                    "body": "Ha prohibido \"como medida de precauci\u00f3n\" la venta de dos lotes.\n\nLa Agencia italiana del F\u00e1rmaco (AIFA) anunci\u00f3 estar investigando el fallecimiento de once personas a quienes en los \u00faltimos d\u00edas se les hab\u00eda suministrado una dosis de la vacuna Fluad, de la compa\u00f1\u00eda Novartis Vaccines and Diagnostics. \"La Aifa est\u00e1 recopilando todos los elementos necesarios para verificar caso por caso los avisos recibidos\", explic\u00f3 la agencia en un comunicado.\n\nEn la nota la AIFA a\u00f1ade que \"por el momento no es posible afirmar que haya una relaci\u00f3n directa entre el suministro de la vacuna y las muertes se\u00f1aladas, dado que esto requiere informaciones m\u00e1s completas que deben ser fruto de cuidados an\u00e1lisis\". El jueves este mismo organismo prohibi\u00f3 como \"medida de precauci\u00f3n\" la venta de dos lotes de esta vacuna tras la muerte de dos personas en Sicilia (sur de Italia) que hab\u00edan sido vacunadas 48 horas antes, una medida que ha suscitado la pol\u00e9mica en el pa\u00eds.\n\nPor esta raz\u00f3n, la AIFA considera \"posible\" que el \"repentino aumento de las notificaciones\" pueda ser fruto del \"impacto medi\u00e1tico sobre la poblaci\u00f3n\". Por el momento, las fiscal\u00edas de las ciudades donde se han producido estas muertes -como las toscanas Prato y Siena (centro)- han abierto una investigaci\u00f3n, seg\u00fan recogen los medios.\n\nEn la nota, la AIFA recuerda \"la importancia de la vacuna contra la gripe\", una enfermedad \"infecciosa seria\" que puede derivar en \"complicaciones graves\".\n\nSeg\u00fan informaron los medios, esta vacuna no ha sido distribuida en el extranjero, sino \u00fanicamente en Italia.",
                    "date": "2014-11-28",
                    "eventUri": "1895631",
                    "id": "26499277",
                    "isDuplicate": false,
                    "lang": "spa",
                    "sim": 0.7512,
                    "source": {
                        "title": "20minutos.es - \u00daltimas Noticias",
                        "uri": "www.20minutos.es"
                    },
                    "time": "22:37:00",
                    "title": "Italia investiga 11 muertes que podr\u00edan deberse a una vacuna ... - 20minutos.es",
                    "uri": "229865369",
                    "url": "http://www.20minutos.es/noticia/2310766/0/italia/muertos/gripe/",
                    "wgt": 1
                },
                {
                    "body": "Se trata de una medida de precauci\u00f3n a la espera de conocerse los resultados de los an\u00e1lisis realizados a dos lotes de la vacuna Fluad, producidos por la farmac\u00e9utica suiza Novartis.\n\nLos fallecimientos se produjeron 48 horas despu\u00e9s de que los pacientes recibieran la vacuna.\n\n\"Estamos frente a un caso excepcional. Solo sabemos que la administraci\u00f3n de la vacuna se realiz\u00f3 dos d\u00edas antes, pero esto no significa que la causa sea la vacuna. Debemos esperar a los resultados de las investigaciones para saber qu\u00e9 sucedi\u00f3\", explica Giancarlo Icardi, delegado de la Sociedad Italiana de Higiene, Medicina Preventiva y Salud P\u00fablica.\n\nLos lotes sospechosos fueron producidos en la f\u00e1brica que Novartis tiene en Siena. Seg\u00fan la compa\u00f1\u00eda, esta vacuna se produce desde 1997 y desde entonces se han administrado m\u00e1s de 65 millones de dosis en todo el mundo.",
                    "date": "2014-11-28",
                    "eventUri": "1895631",
                    "id": "26469974",
                    "isDuplicate": false,
                    "lang": "spa",
                    "sim": 0.6613,
                    "source": {
                        "title": "euronewses",
                        "uri": "es.euronews.com"
                    },
                    "time": "11:51:00",
                    "title": "Italia proh\u00edbe una vacuna contra la gripe tras la muerte de cuatro ... - euronews",
                    "uri": "229767661",
                    "url": "http://es.euronews.com/2014/11/28/italia-prohibe-una-vacuna-contra-la-gripe-tras-la-muerte-de-cuatro-personas/",
                    "wgt": 1
                },
                {
                    "body": "Esta tesis fue sustentada por la doctora Sherri Tenpenny durante una conferencia en Bogot\u00e1 sobre Medicina Funcional.\n\nDurante el evento, celebrado entre el 15 y 17 de noviembre, la doctora en medicina osteop\u00e1tica y activista en torno a la \"oposici\u00f3n argumentada y cient\u00edficamente sustentada contra la vacunaci\u00f3n masiva e indiscriminada\", plante\u00f3 un ruptura anal\u00edtica frente al sentido com\u00fan que se ha venido tejiendo en torno al tema de las vacunas en el pa\u00eds.\n\nEn primer lugar, la doctora Tenpenny se refiri\u00f3 a uno de los temas que m\u00e1s ha generado pol\u00e9mica por estos d\u00edas en Colombia: la vacuna contra el Virus del Papiloma Humano (VPH) y sus aparentes efectos secundarios. Para ella, \"cada vez que hay un tema con una vacuna y con los efectos secundarios, el Gobierno y la industria farmac\u00e9utica hacen lo que est\u00e9 a su alcance para ocultar este hecho y tratar de identificar cualquier otra raz\u00f3n por la cual no fue la vacuna la que caus\u00f3 ese efecto\", manifest\u00f3 en di\u00e1logo con El Espectador.\n\nIgualmente, aclar\u00f3 que pese a que la epidemi\u00f3loga colombiana Nubia Mu\u00f1oz dijo que la relaci\u00f3n entre el virus del VPH y el c\u00e1ncer de cuello uterino est\u00e1 comprobada cient\u00edficamente, y que no es posible rechazar una vacuna que protege contra esa enfermedad, asume que se est\u00e1 diciendo la verdad, pero que no est\u00e1 de acuerdo.\n\nEl argumento de Tenpenny para refutar la posici\u00f3n de Mu\u00f1oz, es que existen \"15 tipos de virus diferentes del papiloma humano, que est\u00e1n relacionados con el c\u00e1ncer de cuello uterino, y dos de estos est\u00e1n en la vacuna. Se ha comprobado que estos dos son los menos frecuentes de todos\", situaci\u00f3n por la que afirmar que es suficiente la vacuna para prevenirlos es decirles a las personas \"que est\u00e1n siendo protegidas de algo, cuando en realidad no lo est\u00e1n\".\n\nEn segundo lugar, la entrevistada se refiri\u00f3 a la vacuna contra el herpes z\u00f3ster, contra la varicela, la tosferina, rotavirus e influenza, as\u00ed como al anunci\u00f3 del grupo farmac\u00e9utico Sanofi-Aventis sobre la llegada de la vacuna contra el dengue, evento sobre el que se manifest\u00f3 de la siguiente manera: \"Si uno se vacuna contra el dengue y no se enferma de dengue, no se sabe si realmente es porque la vacuna funciona o porque no lo pic\u00f3 el mosquito. Si uno recibe la inyecci\u00f3n y genera el anticuerpo, \u00bfc\u00f3mo saber si fue el anticuerpo el que lo protegi\u00f3? En cambio, uno s\u00ed le est\u00e1 metiendo al cuerpo una cantidad de componentes, de los cuales no est\u00e1 seguro qu\u00e9 son\".\n\nSeguidamente, Sherri Tenpenny le dijo a El Espectador que cada uno de los componentes de una vacuna cuenta con \"una hoja de datos de seguridad m\u00e9dica\", mediante los cuales se enuncian los posibles efectos secundarios, pero que no tiene conocimiento de alg\u00fan estudio en donde se advierta \"qu\u00e9 ocurre cuando uno los une o los conjuga y cuando hay cuatro o cinco de estos materiales juntos. Si unimos todos estos componentes, \u00a1es como si se tratara del caldero de una bruja!\".\n\nAl final, la doctora Tenpenny reconoci\u00f3 que los m\u00e9dicos \"tambi\u00e9n presionan para que uno se vacune\", y dijo estar de acuerdo con que a los padres se les inform\u00e9 realmente lo que se les est\u00e1 aplicando a sus hijos.\n\nLas declaraciones de la especialista se publican en el impreso en el marco de la cuarta \"Jornada Nacional de Vacunaci\u00f3n\", con la cual se busca inmunizar a cerca de 240 mil ni\u00f1os de diferentes zonas del pa\u00eds.\n\nAs\u00ed lo dio a conocer el Ministerio de Salud que bajo el lema \"D\u00eda de ponerse al d\u00eda\", lanz\u00f3 un llamado para que este s\u00e1bado 29 de noviembre todos los ni\u00f1os y ni\u00f1as menores de cinco a\u00f1os actualicen su esquema de vacunaci\u00f3n totalmente gratis.",
                    "date": "2014-11-28",
                    "eventUri": "1895631",
                    "id": "26466020",
                    "isDuplicate": false,
                    "lang": "spa",
                    "sim": 0.5955,
                    "source": {
                        "title": "pulzo.com",
                        "uri": "www.pulzo.com"
                    },
                    "time": "10:24:00",
                    "title": "Advierten que jornadas de vacunaci\u00f3n masiva har\u00edan parte de ... - Pulzo",
                    "uri": "229753437",
                    "url": "http://www.pulzo.com/nacion/249871-advierten-que-jornadas-de-vacunacion-masiva-harian-parte-de-experimentos-de-la",
                    "wgt": 1
                },
                {
                    "body": "Hermosillo.- La Secretar\u00eda de Salud en Sonora inform\u00f3 que los casos de dengue que se han registrado en lo que va del a\u00f1o en el estado suman tres mil 783 y nueve personas han muerto a consecuencia de la enfermedad.\n\nEl director de Servicios de Salud a la Comunidad de la dependencia estatal, Francisco Javier Navarro G\u00e1lvez, explic\u00f3 que del total de casos, dos mil 890 son dengue del tipo cl\u00e1sico y 893 corresponden al tipo hemorr\u00e1gico.\n\nEl 53 por ciento del total de casos corresponden a pacientes atendidos en unidades m\u00e9dicas de la Secretar\u00eda de Salud y 36 por ciento en el Instituto Mexicano del Seguro Social (IMSS), en tanto que el resto se han canalizado a otras instituciones, dijo.\n\nSubray\u00f3 que durante la \u00faltima semana no se confirm\u00f3 ninguna defunci\u00f3n en la entidad.\n\nEn tanto que, anot\u00f3, el n\u00famero de hospitalizados por dengue en nosocomios del sector salud suman cien; de ellos, 40 se encuentran en unidades m\u00e9dicas de la Secretar\u00eda de Salud, 43 en el IMSS, ocho en el Isssteson y nueve en el sector privado.\n\nEl funcionario estatal reiter\u00f3 el llamado a la poblaci\u00f3n para mantener las medidas preventivas en sus viviendas y evitar la proliferaci\u00f3n del mosco transmisor.\n\nAlert\u00f3 que aun y cuando las temperaturas han disminuido, el vector sigue reproduci\u00e9ndose en los criaderos del mosco.\n\nNotimex",
                    "date": "2014-11-27",
                    "eventUri": "1895631",
                    "id": "26450377",
                    "isDuplicate": false,
                    "lang": "spa",
                    "sim": 0.3504,
                    "source": {
                        "title": "El Heraldo de Tabasco",
                        "uri": "www.oem.com.mx"
                    },
                    "time": "23:55:00",
                    "title": "Secretaria de Salud reporta ya tres mil 783 casos de dengue en ... - La Prensa (OEM)",
                    "uri": "229687119",
                    "url": "http://www.oem.com.mx/laprensa/notas/n3621493.htm",
                    "wgt": 1
                }
            ]
        },
        "info": {
            "articleCount": 5,
            "averageDate": "2014-11-28",
            "avgCos": 0.445,
            "categories": [],
            "customDate": false,
            "customLocation": false,
            "eventUri": "1895631",
            "extractedDate": "",
            "extractedDateEnd": "",
            "id": "1867091",
            "lang": "spa",
            "storyDate": "2014-11-28",
            "storyDateEnd": "",
            "uri": "e7e700df-6a06-44ea-a4f3-f736278fc36b-357640",
            "variance": 0.302
        }
    },
    "meta": {
        "CCAArticleMatchCount": 7,
        "CCAArticleMatchRatio": 0.08536585365853659,
        "CCAAvgCosSim": 0.7894857142857143,
        "CCAAvgMatchWgt": 44.42857142857143,
        "_articleUri1": "229860865",
        "_articleUri2": "229658053",
        "_datetime": "2015-02-19 11:55:13",
        "_ruleBasedShouldMerge": false,
        "_storyUri1": "e7e700df-6a06-44ea-a4f3-f736278fc36b-357640",
        "_storyUri2": "850f305d-14db-4c75-b547-79470a557ea3-1078310",
        "_username": "Evgenia Belyaeva",
        "artCount1": 5,
        "artCount2": 6,
        "avgCosSimStory1": 0.445,
        "avgCosSimStory2": 0.5796,
        "categorySim": 0,
        "conceptCosSim": 0.3863013438617348,
        "conceptJaccardSim": 0.1940298507462687,
        "coreTime1": 130679.9166666667,
        "coreTime2": 130675.3666666667,
        "coreTimeStDev1": 8.260774782065162,
        "coreTimeStDev2": 4.882041448380306,
        "entityCosSim": 0.689032852589933,
        "entityJaccardSim": 0.4375,
        "extractedDateJaccardSim": 0.5,
        "extractedDatesStory1": 1,
        "extractedDatesStory2": 3,
        "hasSameLocation": -1,
        "keywordCosSim": 0.2310383520030757,
        "keywordJaccardSim": 0.1176470588235294,
        "lang1": "spa",
        "lang2": "eng",
        "matchingDateCount": 1,
        "matchingDateRatio": 0.6666666666666666,
        "ratioAnnotatedArticlesStory1": 1,
        "ratioAnnotatedArticlesStory2": 1,
        "shouldMerge": true,
        "storyQuality1": 6,
        "storyQuality2": 13,
        "timeAvg1": 130693.2266666667,
        "timeAvg2": 130680.0416666667,
        "timeStDev1": 8.260774782065162,
        "timeStDev2": 4.882041448380306,
        "varianceStory1": 0.302,
        "varianceStory2": 0.1641
    }
}